SEB SA INH. EO 1/ FR0000121709 /
10/9/2024 9:09:58 AM | Chg. -1.0000 | Volume | Bid9:10:17 PM | Ask9:12:34 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
101.9000EUR | -0.97% | 0 Turnover: 0.0000 |
102.4000Bid Size: 50 | 102.8000Ask Size: 50 | 5.67 bill.EUR | 2.56% | 14.62 |
GlobeNewswire
7/17
SocialFi Platform RECRD Emerges From Stealth With $4M Funding Led by Sui Foundation & Alphabit Fund;...
GlobeNewswire
6/25
PEAK:AIO Commits to the Future of AI Healthcare; Announces the Appointment of Professor Sebastien Ou...
GlobeNewswire
1/29
Journal of the American Academy of Dermatology Publishes ZORYVE (roflumilast) Foam, 0.3% Results for...
GlobeNewswire
1/22
ZORYVE® (roflumilast) Topical Foam, 0.3%, for the Treatment of Seborrheic Dermatitis Launches in the...
GlobeNewswire
9/25/2023
New Campaign from Arcutis Aims to Educate, Raise Awareness, and Provide Encouragement for Those Livi...
Newsfile Corp
10/10/2022
GaiaLens Unveils its ESG Reporting Capability as Part of its Data-Driven, AI-Based ESG Analytics Pla...
GlobeNewswire
1/27/2022
F2 Strategy’s 2022 Outlook Report Shows Cryptocurrency Adoption, Data Aggregation and Operations Aut...
GlobeNewswire
12/22/2021
MicroEJ and Groupe SEB, leader in small domestic appliances, announce their collaboration in the dev...
GlobeNewswire
11/3/2021
Bestselling 'Beauty of Horror' Creator Alan Robert Launches Whitelist for 'Monster Chompers' NFT Col...
GlobeNewswire
9/16/2021
F2 Strategy Trailblazes WealthTech Space with Record Growth of Outsourced CTO and Consulting Service...
GlobeNewswire
7/12/2021
Arcutis Announces First Patient Enrolled in Phase 3 Clinical Trial of Topical Roflumilast Foam (ARQ-...
GlobeNewswire
5/25/2021
Sinch AB (publ): Sinch completes a directed new share issue of 7,232,077 shares, raising approximate...
GlobeNewswire
5/24/2021
Sinch AB (publ): Sinch evaluates the conditions to carry out a directed new share issue